Terms: = Ovarian cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Prognosis
10 results:
1. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Approach to Neuroendocrine Neoplasm Associated With ovarian Teratoma.
Opalińska M; Sowa-Staszczak A; Olearska H; Ulatowska-Bialas M; Gilis-Januszewska A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2021; 12():770266. PubMed ID: 34917031
[TBL] [Abstract] [Full Text] [Related]
3. cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis.
Lin L; Nong W; Luo B; Ge Y; Zeng X; Li F; Fan R; Zhang Q; Xie X
Immun Inflamm Dis; 2021 Dec; 9(4):1759-1770. PubMed ID: 34528758
[TBL] [Abstract] [Full Text] [Related]
4. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract] [Full Text] [Related]
5. ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma.
Bi R; Bai Q; Zhu X; Tu X; Cai X; Jiang W; Xu X; Tang S; Ge H; Chang B; Cheng Y; Gan H; Zhou X; Yang W
Diagn Pathol; 2019 Aug; 14(1):96. PubMed ID: 31455365
[TBL] [Abstract] [Full Text] [Related]
6. Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.
Makker A; Goel MM
Endocr Relat Cancer; 2016 Feb; 23(2):R85-R111. PubMed ID: 26538531
[TBL] [Abstract] [Full Text] [Related]
7. Distribution of estrogen and progesterone receptors isoforms in endometrial cancer.
Kreizman-Shefer H; Pricop J; Goldman S; Elmalah I; Shalev E
Diagn Pathol; 2014 Mar; 9():77. PubMed ID: 24684970
[TBL] [Abstract] [Full Text] [Related]
8. Thyroid transcription factor-1 (ttf-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus.
Ervine A; Leung S; Gilks CB; McCluggage WG
Histopathology; 2014 May; 64(6):840-6. PubMed ID: 24267480
[TBL] [Abstract] [Full Text] [Related]
9. Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations.
Dehner LP; Jarzembowski JA; Hill DA
Mod Pathol; 2012 Apr; 25(4):602-14. PubMed ID: 22157934
[TBL] [Abstract] [Full Text] [Related]
10. Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis.
Chang KH; Lee JP; Ryu HS
Int J Gynecol Cancer; 2006; 16 Suppl 1():322-6. PubMed ID: 16515614
[TBL] [Abstract] [Full Text] [Related]
